BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18420158)

  • 1. Management of neurogenic orthostatic hypotension: an update.
    Low PA; Singer W
    Lancet Neurol; 2008 May; 7(5):451-8. PubMed ID: 18420158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
    Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
    Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Orthostatic Hypotension in Parkinson's Disease.
    Fanciulli A; Leys F; Falup-Pecurariu C; Thijs R; Wenning GK
    J Parkinsons Dis; 2020; 10(s1):S57-S64. PubMed ID: 32716319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
    Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
    Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthostatic hypotension: managing a difficult problem.
    Jones PK; Shaw BH; Raj SR
    Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1263-76. PubMed ID: 26427904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of neurogenic orthostatic hypotension.
    Arbique D; Cheek D; Welliver M; Vongpatanasin W
    J Am Med Dir Assoc; 2014 Apr; 15(4):234-9. PubMed ID: 24388946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterase inhibition in patients with orthostatic intolerance.
    Singer W; Opfer-Gehrking TL; Nickander KK; Hines SM; Low PA
    J Clin Neurophysiol; 2006 Oct; 23(5):476-81. PubMed ID: 17016160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthostatic hypotension: evaluation and treatment.
    Maule S; Papotti G; Naso D; Magnino C; Testa E; Veglio F
    Cardiovasc Hematol Disord Drug Targets; 2007 Mar; 7(1):63-70. PubMed ID: 17346129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the Pathophysiology and Management of Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.
    Park JW; Okamoto LE; Biaggioni I
    Curr Hypertens Rep; 2022 Mar; 24(3):45-54. PubMed ID: 35230654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthostatic Hypotension: Mechanisms, Causes, Management.
    Low PA; Tomalia VA
    J Clin Neurol; 2015 Jul; 11(3):220-6. PubMed ID: 26174784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
    Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of orthostatic hypotension.
    Wieling W; Kaufmann H; Claydon VE; van Wijnen VK; Harms MPM; Juraschek SP; Thijs RD
    Lancet Neurol; 2022 Aug; 21(8):735-746. PubMed ID: 35841911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic orthostatic hypotension: pathophysiology and diagnosis.
    Low PA
    Am J Manag Care; 2015 Oct; 21(13 Suppl):s248-57. PubMed ID: 26790109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Orthostatic Hypotension, Postprandial Hypotension, and Supine Hypertension.
    Shibao CA; Biaggioni I
    Semin Neurol; 2020 Oct; 40(5):515-522. PubMed ID: 33058087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical guide to the treatment of neurogenic orthostatic hypotension.
    Berger MJ; Kimpinski K
    Can J Neurol Sci; 2014 Mar; 41(2):156-63. PubMed ID: 24534025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.
    Espay AJ; LeWitt PA; Hauser RA; Merola A; Masellis M; Lang AE
    Lancet Neurol; 2016 Aug; 15(9):954-966. PubMed ID: 27478953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased baroreflex sensitivity in Parkinson's disease is associated with orthostatic hypotension.
    Blaho A; Šutovský S; Valkovič P; Šiarnik P; Sýkora M; Turčáni P
    J Neurol Sci; 2017 Jun; 377():207-211. PubMed ID: 28477697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthostatic hypotension. A primary care primer for assessment and treatment.
    Sclater A; Alagiakrishnan K
    Geriatrics; 2004 Aug; 59(8):22-7. PubMed ID: 15332413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthostatic Hypotension: JACC State-of-the-Art Review.
    Freeman R; Abuzinadah AR; Gibbons C; Jones P; Miglis MG; Sinn DI
    J Am Coll Cardiol; 2018 Sep; 72(11):1294-1309. PubMed ID: 30190008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Orthostatic hypotension in patients with Parkinson's disease].
    Zalyalova ZA; Khasanova DM; Ilina GR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(6):16-21. PubMed ID: 37382973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.